PATENT CLAIM ANALYSIS

Application Number: 15759084
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "210000"]

Abstract:
The present application relates to novel azetidinimine of formula (I). Wherein R 1 -R 6  are as defined in claim  1 . The azetidinimine of the invention are useful as antibiotics and as inhibitors of a carbapenemases. The present invention thus further relates to their use in antibiotic therapies and their methods of synthesis.

Claim (Index 4):
Compound according to any one of  claims 1  to  3 , characterized in that R 2  and/or R 3  represent a monocyclic aryl, monocyclic heteroaryl or polycyclic aryl fragment optionally substituted by one or several (notably 1 to 3) halogen atoms, COOH, \u2014COO(C 1 -C 6  alkyl), C 1 -C 6  N 3 -substituted alkyl, C 1 -C 6  haloalkyl, C 1 -C 6  alcohol, C 1 -C 6  alkoxy, C 1 -C 6  thioalkyl, C 1 -C 6  acyl, nitro, cyano and/or a COO(C 1 -C 6  alkyl) group wherein the alkyl is substituted by NH 2  or NHCOO(C 1 -C 6 )alkyl or NHCOO(C 1 -C 6 )alkyl(mono or polycyclic C 5 -C 12 )aryl, fragments.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 90.0
- Lexical Diversity: 1.51282
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15029377', '14785034', '14382232', '13356729', '13538399']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8191840831417965
- 35 USC 102 Novelty (BERT): 0.5340406417713067
- Combined Prediction Score: 0.7906697390047475
- Mean Citation Score: 357.41369799999984
- Max Citation Score: 368.19736
- Similarity Product: 296.02287194081305

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test